On-Demand Dialogue Now Available on COVID-19 Rebound, Omicron Subvariants BA.4 and BA.5, Current and Next Generation COVID-19 Vaccines, Pediatric Vaccine Rollout, Monkeypox, and More

Our July 7th Dialogue on a Detailed Discussion on the Latest Issues in COVID-19 Rebound, Omicron Subvariants BA.4 and BA.5, Current and Next Generation COVID-19 Vaccines, Pediatric Vaccine Rollout, Monkeypox, and More, with Drs Yvonne Maldonado (Stanford University), Peter Chin-Hong (University of California San Francisco), and Michael S. Saag (University of Alabama at Birmingham) and moderated by Paul A. Volberding (University of California San Francisco) is now available on-demand here.

If you are interested, please register for our upcoming Special Virtual COVID-19 Symposium titled, COVID-19 Prevention and Management: HIV Coinfection, Outpatient Management, Hospitalization, and Post-COVID-19 Complications, on July 20, 2022, from 8:00 AM – 1:00 PM PT (9:00 AM – 2:00 PM MT; 10:00 AM – 3:00 PM CT; 11:00 AM – 4:00 PM ET) at https://www.iasusa.org/events/virtual-covid-19-update-2022/.

Recent Articles and Resources:

• Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis
• Mosaic RBD Nanoparticles Protect Against Challenge by Diverse Sarbecoviruses in Animal Models
• Demographic and Clinical Characteristics of Confirmed Human Monkeypox Virus Cases in Individuals Attending a Sexual Health Centre in London, UK: An Observational Analysis
• CDC’s Monkeypox Update
• Situational Awareness: Monkeypox Outbreak—United States, June 2022
• NYC Health Department’s Interim Guidance for Treatment of Monkeypox